Aarti Pharmalabs Limited is a premier, publicly listed pharmaceutical company providing high-quality APIs, intermediates, Xanthine derivatives and global CDMO services. We are traded on the Indian stock exchanges under the symbols NSE: AARTIPHARM and BSE: 543748, reflecting our commitment to operational excellence and sustainable value creation for our global partners and shareholders.
Explore our Quarterly Results, Presentation, Concalls, Financial Highlights, Subsidiary Companies Balance Sheets, Press Releases, Memorandum and Articles of Association, Annual Returns and Conference Calls.
Aarti Pharmalabs Limited (hereinafter may be referred as ‘the Company’ or ‘APL’ or ‘Aarti’) business practices have been governed by our values of Care, Integrity and Excellence. In this way, we want to be a reliable partner for our customers, suppliers, employees and shareholders.
We have established ourselves as a well-governed corporation with an excellent reputation as ‘Global Partner of Choice’ - a precious recognition that we want to protect, sustain and develop.
Explore our highly informative annual reports which contain details regarding the annual report theme, company introduction, about Aarti Pharmalabs, our journey, manufacturing and R&D infrastructure, business segment review, chairman's message, managing director's message, performance highlights, Environmental, Social and Governance (ESG), an overview of our chairman emeritus and board of directors, corporate information, etc.